Home›Companies›Biotech & Pharma›Decoy Therapeutics

Decoy Therapeutics, Inc.

Updated Oct 29, 2026·Latest SEC filing Jul 14, 2025·Suggest an edit

About Decoy Therapeutics

Decoy Therapeutics is a private company based in Cambridge, Massachusetts. It has reported $1,200,000 raised in one offering on Form D since April 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 11, 2025Apr 28, 2025amended Jul 14, 2025$1,200,000fully sold20$60,000Debt, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Decoy Therapeutics's Form D filed Jul 14, 2025.

BH
Barbara Hibner
Executive officer and director
FP
Frederick Pierce
Executive officer and director
ML
Michael Lipp
Executive officer
PM
Peter Marschel
Executive officer and director

Sources

  1. SECDecoy Therapeutics, Inc. Form D, filed Apr 28, 2025
  2. SECDecoy Therapeutics, Inc. filing history